Parliamentary Search

Written question asked by Jim Cunningham (Labour) on Tuesday, 1 November 2016, in the House of Commons. It was due for an answer on Thursday, 3 November 2016. It was answered by David Mowat (Conservative) on Friday, 4 November 2016 on behalf of the Department of Health.

Diseases: Medical Treatments

Question

To ask the Secretary of State for Health, pursuant to the Answer of 1 November 2016 to Question 50284, of which diseases and other long-term conditions he has made long-term assessments of future prevalence in the population of the UK; and if he will make a statement.

Answer

An ageing population and increasing multimorbidity means both prevalence of long term conditions (LTCs) and the associated treatment costs to the National Health Service are expected to increase.

The Department’s Long Term Condition Compendium of Information, published in 2012, estimates that over 15 million children, adults and older people in England live with at least one LTC. This figure is set to increase to around 18 million by 2025.

In addition, between 60% and 70% of the total health and care spend in England is associated with caring for people with LTCs. The annual health and social care cost per person per year for a person without an LTC is £1,000, this rises to £3,000 for those with one LTC, and £8,000 for those with three. The additional cost to the NHS and social care for the increase in co-morbidities is likely to be £5 billion in 2018 compared to 2011. The Compendium can be found at the link below:

www.gov.uk/government/uploads/system/uploads/attachment_data/file/216528/dh_134486.pdf

Secondary information

Type
Written question
Reference
51408
Session
2016-17
Related items
Musculoskeletal Disorders
Tuesday, 1 November 2016
Written questions
House of Commons
Diseases: Medical Treatments
Monday, 14 November 2016
Written questions
House of Commons
Grouped for answer
Yes
Subjects
Diseases Medical treatments
Link
View this Written question on www.parliament.uk